Rational Drug Design and the Discovery of the ∆2-1,2,3-Triazolines, A Unique Class of Anticonvulsant and Antiischemic Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|20|2081-2108

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.20, 2003-10, pp. : 2081-2108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preface [Hot Topic: Rational Drug Design and The Discovery of the 1,2,3-Triazolines as a Unique Class of Anticonvulsants and Antiischemic Agents (Guest Editor: Pankaja K. Kadaba)]

By  

Current Medicinal Chemistry, Vol. 10, Iss. 20, 2003-10 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Rational Drug Design and The Discovery of the 1,2,3-Triazolines as a Unique Class of Anticonvulsants and Antiischemic Agents (Guest Editor: Pankaja K. Kadaba)]

By  

Current Medicinal Chemistry, Vol. 10, Iss. 20, 2003-10 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Artificial Intelligence Approaches for Rational Drug Design and Discovery

By  

Current Pharmaceutical Design, Vol. 13, Iss. 14, 2007-05 ,pp. : 1497-1508

Bentham Science Publishers

Access to resources Recommend Favorite

Halogen bonding for rational drug design and new drug discovery

By Lu Yunxiang   Liu Yingtao   Xu Zhijian   Li Haiying   Liu Honglai   Zhu Weiliang  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 375-383

Informa Healthcare

Access to resources Recommend Favorite

Antimalarial Drug Discovery: In Silico Structural Biology and Rational Drug Design

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 304-318

Bentham Science Publishers

Access to resources Recommend Favorite